Skip to Main Content
Table 1—

Baseline data on long-duration type 1 diabetic patients who died or survived during a 7-year follow-up

DeadAliveP
n 27 108  
Age (years) 59.6 ± 12.8 56.4 ± 10.5 0.23 
Men:women 17:10 71:37 0.78 
Duration of diabetes (years) 39.1 ± 6.8 37.7 ± 6.8 0.35 
BMI (kg/m225.4 ± 3.5 26.2 ± 3.4 0.32 
Systolic blood pressure (mmHg) 148 ± 22 143 ± 21 0.25 
Diastolic blood pressure (mmHg) 77 ± 12 77 ± 9 0.99 
HbAIc (%) 7.2 ± 2 6.9 ± 1.3 0.4 
Serum creatinine (μmol/l) 124 ± 78 91 ± 27 0.041 
Total cholesterol (mmol/l) 5.7 ± 1.2 5.5 ± 1.1 0.36 
Triglycerides (mmol/l) 1.5 (0.4–4.3) 1.1 (0.3–8.2) 0.07 
Abnormal albumin excretion (%) 59 18.5 <0.001 
Smoking (%) 56 43 0.22 
Preexisting cardiovascular disease (%) 67 39 0.009 
Use of antihypertensive medication 12 (44) 28 (26) 0.06 
Use of ACE inhibitors 6 (22) 16 (15) 0.35 
DeadAliveP
n 27 108  
Age (years) 59.6 ± 12.8 56.4 ± 10.5 0.23 
Men:women 17:10 71:37 0.78 
Duration of diabetes (years) 39.1 ± 6.8 37.7 ± 6.8 0.35 
BMI (kg/m225.4 ± 3.5 26.2 ± 3.4 0.32 
Systolic blood pressure (mmHg) 148 ± 22 143 ± 21 0.25 
Diastolic blood pressure (mmHg) 77 ± 12 77 ± 9 0.99 
HbAIc (%) 7.2 ± 2 6.9 ± 1.3 0.4 
Serum creatinine (μmol/l) 124 ± 78 91 ± 27 0.041 
Total cholesterol (mmol/l) 5.7 ± 1.2 5.5 ± 1.1 0.36 
Triglycerides (mmol/l) 1.5 (0.4–4.3) 1.1 (0.3–8.2) 0.07 
Abnormal albumin excretion (%) 59 18.5 <0.001 
Smoking (%) 56 43 0.22 
Preexisting cardiovascular disease (%) 67 39 0.009 
Use of antihypertensive medication 12 (44) 28 (26) 0.06 
Use of ACE inhibitors 6 (22) 16 (15) 0.35 

Data are means ± SD, median (range), or n (%). Student’s t test or χ2 test used as appropriate. Serum triglycerides analyzed by Mann-Whitney U test.

Close Modal

or Create an Account

Close Modal
Close Modal